Missing/wrong data?
Log in to edit
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials
scientific article published in May 2012
Author/s
author: Beatriz Grinsztejn, Bonaventura Clotet Sala, Michael Saag, Jean-Michel Molina, Katia Boven, Simon Vanveggel, Pedro Cahn
Work details
Publication date
May 1, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.